Oxidative inactivation of surfactants

Lung

Volumn 177, Issue 3, 1999, Pages 179-189

  Andersson, S ^a,b   Kheiter, A ^b   Merritt, T A ^b,c,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ST CHARLES MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Lipid peroxidation; Protein carbonylation; Pulmonary surfactant; Reactive oxygen species; Surfactant inactivation

Indexed keywords

REACTIVE OXYGEN METABOLITE; SURFACTANT;

ARTICLE; HUMAN; INFANT; LIPID PEROXIDATION; LUNG DYSPLASIA; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

ANIMALS; BIOLOGICAL PRODUCTS; HUMANS; INFANT, NEWBORN; LIPID PEROXIDATION; PULMONARY SURFACTANTS; RABBITS; REACTIVE OXYGEN SPECIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0032937333     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007639     Document Type: Article

References (50)

1. 1. Abman SH, Groothius JR (1994) Pathophysiology and treatment of bronchopulmonary dysplasia. Pediatr Clin North Am 41:277-315
2. 2. Amirkhanian J, Merritt TA (1995) The influence of pH on surface properties of lung surfactants. Lung 173:243-254
3. 3. Amirkhanian JD, Merritt TA (1998) Inhibitory effects of oxyradicals on surfactant function: utilizing in vitro Fenton reaction. Lung 176:63-72
4. 4. Chen PS, Toribara TY, Huber W (1956) Microdetermination of phosphorus. Ann Chem 28:1756-1768
5. 5. Coalson JJ, King RJ, Yanf F, Winter W, Whitsett JA, DeLemos RA, Seidner SR (1995) SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. Am J Respir Crit Care Med 151:854-866
6. 6. Cochrane CG, Revak SD (1994) Protein-phospholipid interactions in pulmonary surfactant. Chest 105:S57-S62
7. 7. Enhorning G (1977) Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43:198-203
8. 8. Gladstone IM, Levine RL (1994) Oxidation of proteins in neonatal lungs. Pediatrics 93:764-768
9. 9. Griese M, Dietrich P, Potz C, Westburg B, Bals R, Reinhardt D (1996) Surfactant subfractions during nosocomial infection in ventilated preterm human neonates. Am J Respir Crit Care Med 153:398-403
10. 10. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP (1994) Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk neonates. Pediatrics 93:712-718
11. 11. Gross NJ, Narine KR (1990) Surfactant subtypes in mice: characterization and quantitation. J Appl Physiol 66:342-349
12. 12. Gross NJ, Schultz R (1990) Serine protease requirement for the extracellular metabolism of pulmonary surfactant. Biochem Biophys Acta 1044:222-230
13. 13. Haagsman HP (1994) Surfactant proteins A and D. Biochem Soc Transact 22:100-106
14. 14. Haddad IY, Crow JP, Hu P, Ye Y, Beckman J, Matalon S (1994) Concurrent generation of nitric oxide and superoxide damages surfactant protein. Am J Physiol 267:L242-L249
15. 15. Halliwell B, Gutteridge JMC (1989) Free Radicals in Biology and Medicine. 2nd ed. Clarendon Press, Oxford, UK
16. 16. Hallman M, Merritt TA, Bry K (1994) The fate of exogenous surfactant in neonates with respiratory distress syndrome. Clin Pharmacokinet 26;215-232
17. 17. Hallman M, Merritt TA, Bry K, Berry C (1993) Association between neonatal care practices and efficacy of exogenous human surfactant: results of a bicenter randomized trial. Pediatrics 91:552-560
18. 18. Hallman M, Spragg R, Harrell JH, Moser KM (1982) Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest 70:673-683
19. 19. Hobar JD, Wright LL, Soll RF, Wright EC, Fanaroff AA, Korones SB, Shankaran S, Oh W, Fletcher BD, Bauer CR, Tyson JE, Lemons JA, Donovan EF, Stoll BJ, Stevenson DD, Papile L-A, Philips J (1996) A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 97:1-6
20. 20. Ischiropoulos H, Zhu L, Beckman JS (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys 298:446-452
21. 21. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, DeLemos R (1996) Undetectable interleukin-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 39:966-975
22. 22. Kalyanaraman B, Sohnle PG (1985) Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants. J Clin Invest 75:1618-22
23. 23. Kooy NW, Royall JA, Kelly DR, Beckman JS (1995) Evidence for in vivo peroxynitrite formation in human acute lung injury. Am J Respir Crit Care Med 151:1250-1254
24. 24. Koppenol WH (1994) Thermodynamic considerations on the formation of reactive species from hypochlorite, superoxide and nitrogen monoxide. Could nitrosyl chloride be produced by neutrophils and macrophages? FEBS Lett 347:5-8
25. 25. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Bong-Whan A, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478
26. 4 Pediatr Res 39:947-952
27. 27. Merritt TA, Amirkhanian JD, Helbock H, Halliwell B, Cross CE (1993) Reduction of the surface-tension-lowering abilities of surfactant after exposure to hypochlorous acid. Biochem J 295:19-22
28. 28. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L (1983) Elastase and α 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome: role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 72:656-666
29. 29. Moison RMW, Palinckx JJS, Roest M, Houdkamp E, Berger HM (1993) Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 341:79-82
30. 30. Moreno JJ, Pryor WA (1992) Inactivation of α 1-proteinase inhibitor by peroxynitrite. Chem Res Toxicol 5:425-431
31. 31. Neuzil J, Darlow BA, Inder TE, Sluis KB, Winterbourn CC, Stocker R (1995) Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feeding. J Pediatr 126:785-790
32. 32. Ogihara T, Okamoto R, Kim H-S, Nagai A, Morinobu T, Moju H, Kamegai H, Hirano K, Ogihara H, Tamai H, Mino M (1996) New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 39:117-119
33. 33. Oosting RS, Greevenbroek MMJ, Verheof J, van Golde LMG, Haagsman HP (1991) Structural and functional changes of surfactant protein A induced by ozone. Am J Physiol 261:L77-L83
34. 34. Pitkonen OM, Hallman M, Andersson SM (1991) Generation of free radicals from lipid emulsion used in parenteral nutrition. Pediatr Res 29:56-59
35. 35. Putman E, van Golde LMG, Haagsman HP (1997) Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 175:75-103
36. 36. Robbins CG, Davis JM, Merritt TA. Amirkhanian J., Sahgal N, Morin FC, Horowitz S (1995) Combined effects of nitric oxide and hyperoxia on surfactant function and pulmonary inflammation. Am J Physiol 269:L545-L550
37. 37. Saugstad OD (1990) Oxygen toxicity in the neonatal period. Acta Paediatr Scand 79:881-892
38. 38. Schraufstätter IU, Browne K, Harris A, Hyslop PA, Jackson JH, Quehenberger O, Cochrane CG (1990) Mechanisms of hypochlorite injury of target cells. J Clin Invest 85:554-562
39. 39. Schwartz RM, Luby AM, Scanion JW, Kellogg RJ (1994) Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 330:1476-1480
40. 40. Seeger W, Lepper H, Wolf HRD, Neuhof H (1985) Alteration of alveolar surfactant function after exposure to oxidative, stress and to oxygenated and native arachidonic acid in vitro, Biochem Biophys Acta 835:58-67
41. 41. Stadtman ER (1993) Oxidation of free amino acids and of amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 62:797-821
42. 42. Srayer DS, Harting E, Sun B, Robertson B (1996) Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. Am J Respir Crit Care Med 153:1116-1122
43. 43. Ueda T, Ikegami M, Jobe A (1994) Surfactant subtypes: in vitro conversion, in vivo function and effects of serum proteins. Am J Respir Crit Care Med 149:1254-1259
44. 44. Varsila E, Hallman M, Andersson S (1994) Postnatal free radical-induced lipid peroxidation is dependent on gestational age. Acta Paediatr 83:692-695
45. 45. Varsila E, Hallman M, Venge P, Andersson S (1995) Closure of patent ductus arteriosus decreases pulmonary myeloperoxidase in premature infants with respiratory distress syndrome. Biol Neonate 67:167-171
46. 46. Varsila E, Pesonen E, Andersson S (1995) Early protein oxidation in the neonatal lung is related to development of chronic lung disease, Acta Paediatr 84:1296-1299
47. 47. Varsila E, Pitknen O, Hallman M, Andersson S (1994) Immaturity-dependent free radical activity in premature infants, Pediatr Res 36:55-59
48. 48. Ward PA, Till GO, Hatjerill JR, Annesley TM, Kunkel RG (1985) Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest 76:517-527
49. 49. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320:365-376
50. 50. Yagi K (1984) Assay for blood plasma or serum. Methods Enzymol 105:328-331